Interaction and dynamics of chemokine receptor CXCR4 binding with CXCL12 and hBD-3

被引:2
|
作者
Penfield, Jackson [1 ]
Zhang, Liqun [2 ]
机构
[1] Tennessee Technol Univ, Chem Engn Dept, Cookeville, TN 38505 USA
[2] Univ Rhode Isl, Chem Engn Dept, Kingston, RI 02881 USA
来源
COMMUNICATIONS CHEMISTRY | 2024年 / 7卷 / 01期
基金
美国国家卫生研究院;
关键词
CRYSTAL-STRUCTURE; HUMAN BETA-DEFENSIN-3; MOLECULAR-DYNAMICS; PROTEIN; ACTIVATION; DIMERIZATION; EXPRESSION; CANCER; DISRUPTION; MODULATION;
D O I
10.1038/s42004-024-01280-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chemokine receptor CXCR4 is involved in diverse diseases. A comparative study was conducted on CXCR4 embedded in a POPC lipid bilayer binding with CXCL12 in full and truncated forms, hBD-3 in wildtype, analog, and mutant forms based on in total 63 mu s all-atom MD simulations. The initial binding structures of CXCR4 with ligands were predicted using HADDOCK docking or random-seed method, then mu s-long simulations were performed to refine the structures. CXCR4&ligand binding structures predicted agree with available literature data. Both kinds of ligands bind stably to the N-terminus, extracellular loop 2 (ECL2), and ECL3 regions of CXCR4; the C2-C3 (K32-R38) region and occasionally the head of hBD-3 bind stably with CXCR4. hBD-3 analogs with Cys11-Cys40 disulfide bond can activate CXCR4 based on the Helix3-Helix6 distance calculation, but not other analogs or mutant. The results provide insight into understanding the dynamics and activation mechanism of CXCR4 receptor binding with different ligands. The chemokine receptor CXCR4 is involved in cancers and diverse diseases, however, molecular details surrounding the binding of different ligands to this receptor remain incomplete. Here, the authors study the binding and interaction between CXCR4 with CXCL12 and hBD-3 in different forms, and find that both ligands can bind with CXCR4 at the same site, and analogs of hBD-3 with a Cys11-Cys40 disulfide bond can activate CXCR4.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer
    Wu, Wei
    Qian, Liyuan
    Chen, Xuedong
    Ding, Boni
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 13217 - 13224
  • [42] Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain
    Garcia-Cuesta, Eva M.
    Martinez, Pablo
    Selvaraju, Karthik
    Ulltjarn, Gabriel
    Pozo, Adrian Miguel Gomez
    D'Agostino, Gianluca
    Gardeta, Sofia
    Quijada-Freire, Adriana
    Gabella, Patricia Blanco
    Roca, Carlos
    Hoyo, Daniel del
    Jimenez-Saiz, Rodrigo
    Garcia-Rubia, Alfonso
    Palacios, Blanca Soler
    Lucas, Pilar
    Ayala-Bueno, Rosa
    Acerete, Noelia Santander
    Carrasco, Yolanda
    Sorzano, Carlos Oscar
    Martinez, Ana
    Campillo, Nuria E.
    Jensen, Lasse D.
    Frade, Jose Miguel Rodriguez
    Santiago, Cesar
    Mellado, Mario
    ELIFE, 2024, 13
  • [43] CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson's Disease
    Bagheri, Vahid
    Khorramdelazad, Hossein
    Hassanshahi, Gholamhossein
    Moghadam-Ahmadi, Amir
    Vakilian, Alireza
    NEUROIMMUNOMODULATION, 2018, 25 (04) : 201 - 205
  • [44] CXCR4 and CXCL12 signaling regulates the development of extrinsic innervation to the colorectum
    Halasy, Viktoria
    Szocs, Emoke
    Soos, Adam
    Kovacs, Tamas
    Pecsenye-Fejszak, Nora
    Hotta, Ryo
    Goldstein, Allan M.
    Nagy, Nandor
    DEVELOPMENT, 2023, 150 (08):
  • [45] The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy
    Zhou Yu
    Cao Han-Bo
    Li Wen-Jun
    Zhao Li
    CHINESE JOURNAL OF NATURAL MEDICINES, 2018, 16 (11) : 801 - 810
  • [46] Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia
    Ladikou, Eleni E.
    Chevassut, Timothy
    Pepper, Chris J.
    Pepper, Andrea G. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) : 815 - 825
  • [47] CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy
    Mezzapelle, Rosanna
    Leo, Manuela
    Caprioglio, Francesca
    Colley, Liam S.
    Lamarca, Andrea
    Sabatino, Lina
    Colantuoni, Vittorio
    Crippa, Massimo P.
    Bianchi, Marco E.
    CANCERS, 2022, 14 (09)
  • [48] CXCL12/CXCR4 signaling in glioma stem cells-prospects for therapeutic intervention
    Miyazaki, Tsubasa
    Uemae, Yoji
    Ishikawa, Eiichi
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S434 - S437
  • [49] Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma
    Rave-Fraenk, Margret
    Tehrany, Narges
    Kitz, Julia
    Leu, Martin
    Weber, Hanne Elisabeth
    Burfeind, Peter
    Schliephake, Henning
    Canis, Martin
    Beissbarth, Tim
    Reichardt, Holger Michael
    Wolff, Hendrik Andreas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (01) : 47 - 54
  • [50] Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside
    Cho, Byung-Sik
    Kim, Hee-Je
    Konopleva, Marina
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (02) : 248 - 257